PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Comparison of short-term outcomes between laparoscopic-assisted and open complete mesocolic excision (CME) for the treatment of transverse colon cancer.

Abstract Colorectal cancer (CRC) is the third most common cancer worldwide. Although laparoscopic-assisted complete mesocolic excision (LCME) is a superior treatment, there are few studies available on it owe to the low incidence and technical difficulty of LCME in transverse colon cancer.
PMID
Related Publications

Short-term and oncologic outcomes of laparoscopic and open complete mesocolic excision and central ligation.

Comparison of laparoscopic versus open complete mesocolic excision for right colon cancer.

Laparoscopic Complete Mesocolic Excision versus Open Complete Mesocolic Excision for Transverse Colon Cancer: Long-Term Survival Results of a Prospective Single Centre Non-Randomized Study.

Complete mesocolic excision with D3 lymph node dissection in laparoscopic colectomy for stages II and III colon cancer: long-term oncologic outcomes in 168 patients.

Laparoscopic-assisted versus open complete mesocolic excision and central vascular ligation for right-sided colon cancer.

Authors

Mayor MeshTerms
Keywords

Laparoscopy

complete mesocolic excision (CME)

short-term outcomes

transverse colon cancer

Journal Title chinese clinical oncology
Publication Year Start




PMID- 28285536
OWN - NLM
STAT- MEDLINE
DA  - 20170313
DCOM- 20170315
LR  - 20170315
IS  - 2304-3873 (Electronic)
IS  - 2304-3865 (Linking)
VI  - 6
IP  - 1
DP  - 2017 Feb
TI  - Comparison of short-term outcomes between laparoscopic-assisted and open complete
      mesocolic excision (CME) for the treatment of transverse colon cancer.
PG  - 6
LID - 10.21037/cco.2017.01.01 [doi]
AB  - BACKGROUND: Colorectal cancer (CRC) is the third most common cancer worldwide.
      Although laparoscopic-assisted complete mesocolic excision (LCME) is a superior
      treatment, there are few studies available on it owe to the low incidence and
      technical difficulty of LCME in transverse colon cancer. METHODS: The clinical
      data of 78 patients with transverse colon cancer who were treated by LCME and
      open complete mesocolic excision (OCME) were retrospectively analyzed. A total of
      39 cases had been treated by LCME, compared with 39 cases treated by OCME. The
      patient characteristics and short-term outcomes including operation time,
      intra-operative blood loss, length of incision, time to first flatus, first
      postoperative ambulation, postoperative hospitalization time, number of harvested
      lymph nodes, length of resected specimen and incidence of complications were
      evaluated. RESULTS: There was no case converted to OCME in LCME group. LCME had
      significantly shorter length of incision, shorter operation time, less
      intra-operative blood loss, shorter postoperative hospitalization time (P<0.05). 
      The length of resected specimen and the numbers of harvested lymph nodes were
      (26.5+/-5.4 cm) and (16.2+/-3.1) in LCME group, and (24.8+/-4.9 cm) and
      (15.1+/-3.5) in OCME group, with no differences between two groups. The incidence
      of wound infection was lower while the incidence of lymphatic leakage,
      anastomotic leakage, urinary tract infection and wound dehiscence had no
      significant differences between two groups. None of patients in these two groups 
      developed urinary retention, anastomotic bleeding and postoperative intestinal
      obstruction. CONCLUSIONS: Our findings suggested that LCME is a safe, feasible
      and effective treatment method for the treatment of transverse colon cancer due
      to it can provide superior short-term outcomes including less intra-operative
      blood loss, faster recovery and lower incidence of wound infection.
FAU - Wang, Yong
AU  - Wang Y
AD  - Department of Colorectal Surgery, The First Affiliated Hospital of Nanjing
      Medical University, Nanjing 210029, China.
FAU - Zhang, Chuan
AU  - Zhang C
AD  - Department of Colorectal Surgery, The First Affiliated Hospital of Nanjing
      Medical University, Nanjing 210029, China.
FAU - Feng, Yi-Fei
AU  - Feng YF
AD  - Department of Colorectal Surgery, The First Affiliated Hospital of Nanjing
      Medical University, Nanjing 210029, China.
FAU - Fu, Zan
AU  - Fu Z
AD  - Department of Colorectal Surgery, The First Affiliated Hospital of Nanjing
      Medical University, Nanjing 210029, China.
FAU - Sun, Yue-Ming
AU  - Sun YM
AD  - Department of Colorectal Surgery, The First Affiliated Hospital of Nanjing
      Medical University, Nanjing 210029, China. [email protected]
LA  - eng
PT  - Clinical Trial
PT  - Comparative Study
PT  - Journal Article
PL  - China
TA  - Chin Clin Oncol
JT  - Chinese clinical oncology
JID - 101608375
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Anastomotic Leak/etiology
MH  - Blood Loss, Surgical
MH  - Colectomy/*methods
MH  - Colon, Transverse/pathology/surgery
MH  - Colonic Neoplasms/pathology/*surgery
MH  - Female
MH  - Humans
MH  - Laparoscopy/*methods
MH  - Lymph Node Excision
MH  - Male
MH  - Mesocolon/pathology/surgery
MH  - Middle Aged
MH  - Operative Time
MH  - Postoperative Complications/etiology
MH  - Retrospective Studies
MH  - Treatment Outcome
OTO - NOTNLM
OT  - *Laparoscopy
OT  - *complete mesocolic excision (CME)
OT  - *short-term outcomes
OT  - *transverse colon cancer
EDAT- 2017/03/14 06:00
MHDA- 2017/03/16 06:00
CRDT- 2017/03/14 06:00
PHST- 2016/10/10 [received]
PHST- 2016/12/21 [accepted]
AID - 10.21037/cco.2017.01.01 [doi]
PST - ppublish
SO  - Chin Clin Oncol. 2017 Feb;6(1):6. doi: 10.21037/cco.2017.01.01.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>